<DOC>
	<DOCNO>NCT01607268</DOCNO>
	<brief_summary>This research study conduct patient primary autonomic failure , disable condition associate low blood pressure upon stand . These patient also able control change blood pressure due loss cardiovascular reflex mediate within brain . The purpose study determine whether magnetic resonance spectroscopy ( MRS ) , non-invasive imaging technique , measure level chemical ( neurotransmitter ) dorsal medulla , brain area important control cardiovascular function , autonomic failure patient . Importantly , study determine whether difference brain chemical patient peripheral versus central origin autonomic failure . The hypothesis neurotransmitter profile medulla intact patient peripheral autonomic failure compare central impairment . Overall , study provide insight understand mechanism involve autonomic failure determine whether single session MRS image improve ability make accurate diagnosis patient . This would lessen need extensive invasive clinical testing .</brief_summary>
	<brief_title>Magnetic Resonance Spectroscopy Autonomic Failure</brief_title>
	<detailed_description />
	<mesh_term>Atrophy</mesh_term>
	<mesh_term>Multiple System Atrophy</mesh_term>
	<mesh_term>Shy-Drager Syndrome</mesh_term>
	<mesh_term>Pure Autonomic Failure</mesh_term>
	<mesh_term>Neurotransmitter Agents</mesh_term>
	<criteria>Patients primary autonomic failure already participate approve Vanderbilt study `` Evaluation Treatment Autonomic Failure '' Males female race 18 80 year age Able willing provide inform consent Pregnant woman Patients diagnose Parkinson 's Disease secondary form autonomic failure Patients severe claustrophobia Patients take medication know affect brain neurotransmitter level [ e.g. , antidepressant , barbiturate , benzodiazepine , gabapentin , namenda , sinemet ] Patients implant medical device [ e.g. , pacemaker , metal clip , cochlear implant , orthopedic hardware ] , leadbased tattoo piece metal close important organ Highrisk patient [ e.g. , heart failure , symptomatic coronary artery disease , liver impairment , history stroke myocardial infarction ] Inability give withdraw inform consent Other factor investigator 's opinion would prevent subject complete protocol include significant abnormality clinical , mental , laboratory testing</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>January 2017</verification_date>
	<keyword>autonomic failure</keyword>
	<keyword>mangenetic resonance</keyword>
	<keyword>neurochemistry</keyword>
	<keyword>neurotransmitter</keyword>
	<keyword>glutamate</keyword>
</DOC>